Health care law organization Frier Levitt has analyzed FDA enforcement actions in opposition to “study only” peptide suppliers. Their summary: the FDA considers a product’s classification based upon its intended use, not its disclaimers. When Internet websites contain dosage guides, reconstitution Guidance, or website link to boards speaking